Acetyl-CoA metabolism as a therapeutic target for cancer
Open Access
- 19 October 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 168, 115741
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82072801)
- National Natural Science Foundation of China (82173316)
- National Natural Science Foundation of China (82293663)
This publication has 306 references indexed in Scilit:
- The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cellsCell Death & Disease, 2013
- PDK1 inhibition is a novel therapeutic target in multiple myelomaBritish Journal of Cancer, 2012
- Targeting Pioneering Factor and Hormone Receptor Cooperative Pathways to Suppress Tumor ProgressionCancer Research, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth GenesMolecular Cell, 2011
- Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongationBiochemical Pharmacology, 2011
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer PathogenesisCell, 2010
- Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomasInternational Journal of Cancer, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Statins and cancer preventionNature Reviews Cancer, 2005